Biosimilar manufacturers are creating generic versions of biologics and beginning the process of filing for approval once they come off patent. Each year, generics manufacturers offer affordable treatment options for patients and provide needed medication when critical drugs are in short supply. For these manufacturers, the race to be the first to file their drug…

With the continued introduction of biologic therapies, forward-thinking manufacturers will continue to re-examine and refine process scale-up practices. As with any manufacturing industry, drug delivery technology companies are faced with adjusting manufacturing processes to meet expanded demand for certain products—this concept is often referred to as ‘process scale-up.’ In recent years, the introduction of biologic…